AstraZeneca shares tumble 7% after reported Bristol Myers talks

AstraZeneca shares tumbled 7% in early ​trading on Monday following reports of ‌talks between the European pharmaceutical giant and U.S.-based Bristol Myers Squibb , baffling investors and analysts.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。